Harbor BioSciences (HRBR) Financial Statements
Harbor BioSciences Financial Overview
Harbor BioSciences's market cap is currently $140.23M. The company's EPS TTM is $-0.00; its P/E ratio is -8.49; Harbor BioSciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 202.38M | $ 199.21M | $ 280.86M | $ 247.58M |
| Gross Profit | $ 0.00 | $ -11.28M | $ -15.53M | $ 70.86M | $ 64.79M |
| Operating Income | $ 0.00 | $ -24.20M | $ -36.87M | $ 55.87M | $ 105.17M |
| EBITDA | $ 0.00 | $ 7.71M | $ 6.19M | $ 82.19M | $ 145.45M |
| Net Income | $ 30.00K | $ -17.18M | $ -15.98M | $ 39.11M | $ 92.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 111.97M | $ 113.52M | $ 187.16M | $ 175.54M |
| Total Assets | $ 0.00 | $ 204.45M | $ 236.30M | $ 382.65M | $ 399.40M |
| Total Debt | $ 1.31M | $ 8.45M | $ 12.22M | $ 76.44M | $ 87.85M |
| Net Debt | $ 1.31M | $ -6.51M | $ -8.55M | $ 43.10M | $ 50.68M |
| Total Liabilities | $ 6.22M | $ 45.64M | $ 59.66M | $ 138.24M | $ 180.64M |
| Stockholders' Equity | $ 158.79M | $ 158.81M | $ 176.64M | $ 244.41M | $ 218.76M |
| Cash Flow | |||||
| Free Cash Flow | $ -32.30M | $ 10.38M | $ -16.51M | $ 39.52M | $ 90.58M |
| Operating Cash Flow | $ -32.30M | $ 13.29M | $ -12.03M | $ 45.03M | $ 94.21M |
| Investing Cash Flow | $ 30.83M | $ -5.34M | $ 60.27M | $ -29.73M | $ -143.13M |
| Financing Cash Flow | $ -46.00K | $ -13.86M | $ -60.90M | $ -19.74M | $ -43.65M |
Currency in USD